Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening.

Improved in vitro models are needed to better understand cancer progression and bridge the gap between in vitro proof-of-concept studies, in vivo validation, and clinical application. Multicellular tumor spheroids (MCTS) are a popular method for three-dimensional (3D) cell culture, because they capture some aspects of the dimensionality, cell-cell contact, and cell-matrix interactions seen in vivo. Many approaches exist to create MCTS from cell lines, and they have been used to study tumor cell invasion, growth, and how cells respond to drugs in physiologically relevant 3D microenvironments. However, there are several discrepancies in the observations made of cell behaviors when comparing between MCTS formation methods. To resolve these inconsistencies, we created and compared the behavior of breast, prostate, and ovarian cancer cells across three MCTS formation methods: in polyNIPAAM gels, in microwells, or in suspension culture. These methods formed MCTS via proliferation from single cells or passive aggregation, and therefore showed differential reliance on genes important for cell-cell or cell-matrix interactions. We also found that the MCTS formation method dictated drug sensitivity, where MCTS formed over longer periods of time via clonal growth were more resistant to treatment. Toward clinical application, we compared an ovarian cancer cell line MCTS formed in polyNIPAAM with cells from patient-derived malignant ascites. The method that relied on clonal growth (PolyNIPAAM gel) was more time and cost intensive, but yielded MCTS that were uniformly spherical, and exhibited the most reproducible drug responses. Conversely, MCTS methods that relied on aggregation were faster, but yielded MCTS with grapelike, lobular structures. These three MCTS formation methods differed in culture time requirements and complexity, and had distinct drug response profiles, suggesting the choice of MCTS formation method should be carefully chosen based on the application required.

[1]  R. Bjerkvig,et al.  Effects of EGF, BFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain‐tumour biopsies In Vitro , 1993, International journal of cancer.

[2]  S. Beissert,et al.  Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing , 2013, Cell Death and Disease.

[3]  Silviya P Zustiak,et al.  Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. , 2010, Biomacromolecules.

[4]  L. weiswald,et al.  Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.

[5]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.

[6]  S. Parsons,et al.  Pattern and prognostic factors in patients with malignant ascites: a retrospective study. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  M. Eberl,et al.  Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL , 2011, Breast Cancer Research.

[8]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[9]  Hossein Tavana,et al.  Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors , 2016, Advanced healthcare materials.

[10]  J. Dopazo,et al.  Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin , 2013, PloS one.

[11]  D. Wallwiener,et al.  Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations. , 2004, European Journal of Gynaecological Oncology.

[12]  Jay C. Sy,et al.  Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery , 2012, Advanced materials.

[13]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[14]  B. Ducommun,et al.  Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer , 2012, BMC Cancer.

[15]  J. Yuhas,et al.  Multicellular tumor spheroid formation by breast cancer cells isolated from different sites. , 1978, Cancer research.

[16]  S. Narod Have we given up on a cure for ovarian cancer? , 2015, Current oncology.

[17]  S. Leenstra,et al.  Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration , 2005, Journal of Cancer Research and Clinical Oncology.

[18]  Juergen Friedrich,et al.  Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge? , 2007, International journal of radiation biology.

[19]  James P. Freyer,et al.  The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.

[20]  S. Takayama,et al.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[21]  K. Cheung,et al.  Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing. , 2010, Lab on a chip.

[22]  A. Mes-Masson,et al.  Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids , 2008, BMC Genomics.

[23]  P. Sorger,et al.  Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.

[24]  S. Kalloger,et al.  Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation , 2011, International journal of molecular sciences.

[25]  M. Hung,et al.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010 .

[26]  Keiran S. M. Smalley,et al.  Life ins't flat: Taking cancer biology to the next dimension , 2006, In Vitro Cellular & Developmental Biology - Animal.

[27]  Liju Yang,et al.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.

[28]  E. Keller,et al.  Type I Collagen Receptor (α2β1) Signaling Promotes the Growth of Human Prostate Cancer Cells within the Bone , 2006 .

[29]  Gordon B Mills,et al.  Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. , 2012, Cancer cell.

[30]  S. Eccles,et al.  Tumor spheroid-based migration assays for evaluation of therapeutic agents. , 2013, Methods in molecular biology.

[31]  T. Matsushita,et al.  Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. , 2011, Journal of bioscience and bioengineering.

[32]  Vladimir P Torchilin,et al.  Cancer cell spheroids as a model to evaluate chemotherapy protocols , 2012, Cancer biology & therapy.

[33]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[34]  Raha Abdul Rahim,et al.  Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT Assay , 2012, PloS one.

[35]  Shuichi Takayama,et al.  High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. , 2011, The Analyst.

[36]  R. Sutherland,et al.  Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. , 1971, Journal of the National Cancer Institute.

[37]  Benjamin Haibe-Kains,et al.  Inconsistency in large pharmacogenomic studies , 2013, Nature.

[38]  H. Thierens,et al.  Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma. , 2004, Canadian journal of physiology and pharmacology.

[39]  KR Stevens,et al.  InVERT molding for scalable control of tissue microarchitecture , 2013, Nature Communications.

[40]  Brendon M. Baker,et al.  Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues , 2012, Journal of Cell Science.

[41]  A. Shiras,et al.  Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines , 2004, Clinical & Experimental Metastasis.

[42]  Ying Zhang,et al.  Development of an in Vitro Multicellular Tumor Spheroid Model Using Microencapsulation and Its Application in Anticancer Drug Screening and Testing , 2008, Biotechnology progress.

[43]  G. Mor,et al.  Apoptosis-Based Evaluation of Chemosensitivity in Ovarian Cancer Patients , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[44]  P. Zandstra,et al.  Reproducible, Ultra High-Throughput Formation of Multicellular Organization from Single Cell Suspension-Derived Human Embryonic Stem Cell Aggregates , 2008, PloS one.

[45]  Maria Teresa Santini,et al.  Three-Dimensional Spheroid Model in Tumor Biology , 1999, Pathobiology.

[46]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[47]  J. Jardillier,et al.  Multicellular resistance: a paradigm for clinical resistance? , 2000, Critical reviews in oncology/hematology.

[48]  S. Howell,et al.  Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. , 2012, Neoplasia.

[49]  J. Meléndez-Zajgla,et al.  Transcriptome profile of the early stages of breast cancer tumoral spheroids , 2016, Scientific Reports.

[50]  D. Alberts,et al.  Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide) , 2004, Investigational New Drugs.

[51]  M. Hung,et al.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010, Breast cancer : basic and clinical research.

[52]  R. Chen,et al.  Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance , 2009, Cell cycle.

[53]  S. Wilhelm,et al.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.

[54]  Maria Vinci,et al.  Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation , 2012, BMC Biology.

[55]  Marilena Loizidou,et al.  3D tumour models: novel in vitro approaches to cancer studies , 2011, Journal of Cell Communication and Signaling.

[56]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[57]  Alessandro Bevilacqua,et al.  3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained , 2016, Scientific Reports.

[58]  N. Ahmed,et al.  Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research , 2013, Front. Oncol..

[59]  Anne-Marie Mes-Masson,et al.  Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) , 2007, Molecular carcinogenesis.

[60]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[61]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[62]  Hwan-You Chang,et al.  Recent advances in three‐dimensional multicellular spheroid culture for biomedical research , 2008, Biotechnology journal.

[63]  W. Mueller‐Klieser Three-dimensional cell cultures: from molecular mechanisms to clinical applications. , 1997, American journal of physiology. Cell physiology.

[64]  C. Perou,et al.  The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.

[65]  Joshua M. Stuart,et al.  Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.

[66]  S. Kaye,et al.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research , 2013, Nature Reviews Cancer.

[67]  W. Mueller‐Klieser Tumor biology and experimental therapeutics. , 2000, Critical reviews in oncology/hematology.

[68]  Vítor M Gaspar,et al.  3D tumor spheroids: an overview on the tools and techniques used for their analysis. , 2016, Biotechnology advances.

[69]  M. Platt,et al.  Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk , 2015, Scientific Reports.

[70]  A. Skubitz,et al.  Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. , 2001, The American journal of pathology.